Marketing-Börse PLUS - Fachbeiträge zu Marketing und Digitalisierung
print logo

EpiCast Report: Psoriasis - Epidemiology Forecast to 2024 Classification, Prevention, Treatment and Updates Report

The Psoriasis EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for psoriasis .
MarketsandMarkets™ | 16.02.2016

EpiCast Report: Psoriasis - Epidemiology Forecast to 2024 Size and Share Published in 2015-10-14 Available for US$ 3995 at Researchmoz.us

Description

Psoriasis is a chronic,
immune-mediated inflammatory skin disease. Psoriasis ranges in severity from a few scattered, sharply demarcated, scaly, red, coin-sized skin lesions or scaly plaques to involvement of almost the entire body surface. Psoriasis is more prevalent in colder areas, and less prevalent in the tropics and warmer regions of the world. Globally, the one-year prevalence of psoriasis varies with the differences in prevalence of psoriasis attributed to variations in environmental factors, genetic factors, and differences in the case definition used to diagnose psoriasis in epidemiology studies.

GlobalData epidemiologists forecast an increase in the one-year diagnosed prevalent cases of psoriasis in the 8MM, from 43,747,201 cases in 2014 to 50,455,013 cases in 2024, with an Annual Growth Rate (AGR) of 1.53% during the forecast period. In 2024, India will have the highest number of one-year diagnosed prevalent cases of psoriasis in the 8MM, with 32,853,676 cases, whereas Japan will have the lowest number of one-year diagnosed prevalent cases of psoriasis, with 482,431 cases in 2024.

This report provides an overview of the risk factors, comorbidities, and the global and historical trends for psoriasis in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and India). The report also provides a 10-year epidemiological forecast of the one-year diagnosed prevalent cases of psoriasis segmented by sex, age (at 10-year intervals, starting at age zero years and ending at ages =80 years), and severity (mild, moderate, and severe) in the 8MM.

Download Sample of this Report at: http://www.researchmoz.us/enquiry.php?type=S&repid=466519

Scope


- The Psoriasis EpiCast Report provides an overview of the risk factors, comorbidities, and the global and historical trends for psoriasis in the eight major markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and India). The report also provides a 10-year epidemiological forecast of the one-year diagnosed prevalent cases of psoriasis segmented by sex, age (at 10-year intervals, starting at age zero years and ending at ages =80 years), and severity (mild, moderate, and severe) in the 8MM. GlobalData epidemiologists forecast the one-year diagnosed prevalent cases of psoriasis in the 8MM from 20142024 using data obtained from peer-reviewed journals that provide one-year diagnosed prevalence of psoriasis in the respective markets. Psoriasis one-year diagnosed prevalent cases are further segmented by severity.

- The psoriasis epidemiology report is written and developed by Masters- and PhD-level epidemiologists.

- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.

Reasons to buy

The Psoriasis EpiCast series will allow you to -

- Develop business strategies by understanding the trends shaping and driving the global psoriasis market.

- Quantify patient populations in the global psoriasis market to improve product design, pricing, and launch plans.

- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for psoriasis therapeutics in each of the markets covered.

Make an Enquiry: http://www.researchmoz.us/enquiry.php?type=E&repid=466519

Table of Content


1 Table of Contents 4

1.1 List of Tables 5

1.2 List of Figures 6

2 Introduction 7

2.1 Catalyst 7

2.2 Related Reports 8

2.3 Upcoming Related Reports 8

3 Epidemiology 9

3.1 Disease Background 9

3.2 Risk FThe EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
actors and Comorbidities 9

3.3 Global Trends 10

3.3.1 Prevalence 10

3.4 Forecast Methodology 12

3.4.1 Sources Used for One-Year Diagnosed Prevalence of Psoriasis 13

3.4.2 Sources Not Used 16

3.4.3 Forecast Assumptions and Methods, One-Year Diagnose

Browse All Pharmaceutical Market Research Reports at http://www.researchmoz.us/pharmaceutical-market-reports-38.html

About ResearchMoz

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives.

Contact Us:

ResearchMoz
Mr. Nachiket Ghumare, +1-518-621-2074
USA-Canada Toll Free: 866-997-4948
sales@researchmoz.us
http://www.researchmoz.us/

For More Report Click Here @ http://www.prweb.com/search.aspx?search-releases=researchmoz&hitsPerPage=20





Img of MarketsandMarkets™
About the tenderer: MarketsandMarkets™

MarketsandMarkets is the largest market research firm worldwide in terms of annually published premium market research reports.